Rachel E. Carlson

1.7k total citations
41 papers, 751 citations indexed

About

Rachel E. Carlson is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Surgery. According to data from OpenAlex, Rachel E. Carlson has authored 41 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 11 papers in Cancer Research and 7 papers in Surgery. Recurrent topics in Rachel E. Carlson's work include Prostate Cancer Treatment and Research (29 papers), Prostate Cancer Diagnosis and Treatment (22 papers) and Cancer, Lipids, and Metabolism (5 papers). Rachel E. Carlson is often cited by papers focused on Prostate Cancer Treatment and Research (29 papers), Prostate Cancer Diagnosis and Treatment (22 papers) and Cancer, Lipids, and Metabolism (5 papers). Rachel E. Carlson collaborates with scholars based in United States, Italy and Canada. Rachel E. Carlson's co-authors include R. Jeffrey Karnes, Laureano J. Rangel, Stephen A. Boorjian, Eric J. Bergstralh, Paul L. Crispen, Alessandro Morlacco, Michael L. Blute, Manish Kohli, Vidit Sharma and Boyd R. Viers and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Lancet Oncology.

In The Last Decade

Rachel E. Carlson

37 papers receiving 741 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rachel E. Carlson United States	15	610	156	155	141	138	41	751
Michelle H. Braccioforte United States	18	662 1.1×	88 0.6×	92 0.6×	121 0.9×	100 0.7×	52	786
Ignacio F. San Francisco Chile	16	588 1.0×	60 0.4×	188 1.2×	95 0.7×	157 1.1×	35	823
Theo de Reijke Netherlands	15	840 1.4×	264 1.7×	128 0.8×	101 0.7×	230 1.7×	31	1.1k
Lorenzo Tosco Belgium	14	629 1.0×	143 0.9×	133 0.9×	109 0.8×	154 1.1×	42	751
Dennis L. Broyles United States	10	809 1.3×	183 1.2×	131 0.8×	148 1.0×	166 1.2×	17	1.0k
Marcus V. Sadi Brazil	10	426 0.7×	120 0.8×	85 0.5×	86 0.6×	174 1.3×	22	632
Phillip Rubin United States	4	983 1.6×	111 0.7×	116 0.7×	91 0.6×	62 0.4×	10	1.1k
F. Gómez-Veiga Spain	14	707 1.2×	196 1.3×	76 0.5×	159 1.1×	113 0.8×	81	899
A.V. D’Amico United States	7	812 1.3×	105 0.7×	157 1.0×	119 0.8×	85 0.6×	16	924
C. Bangma Netherlands	4	806 1.3×	156 1.0×	94 0.6×	243 1.7×	91 0.7×	7	944

Countries citing papers authored by Rachel E. Carlson

Since Specialization

Citations

This map shows the geographic impact of Rachel E. Carlson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel E. Carlson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel E. Carlson more than expected).

Fields of papers citing papers by Rachel E. Carlson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel E. Carlson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel E. Carlson. The network helps show where Rachel E. Carlson may publish in the future.

Co-authorship network of co-authors of Rachel E. Carlson

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel E. Carlson. A scholar is included among the top collaborators of Rachel E. Carlson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel E. Carlson. Rachel E. Carlson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yost, Kathleen J., Rachel E. Carlson, Jennifer Laffin, et al.. (2024). Recruitment strategies and consent rates in a national prospective colorectal cancer screening cohort: results from year 1 of the Voyage Study. BMJ Open Gastroenterology. 11(1). e001376–e001376. 1 indexed citations

Sicotte, Hugues, Krishna R. Kalari, Sisi Qin, et al.. (2022). Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone Treatment. Molecular Cancer Research. 20(12). 1739–1750. 9 indexed citations

Jiménez, Rafael E., Thomas D. Atwell, Bruce W. Eckloff, et al.. (2019). A Prospective Correlation of Tissue Histopathology With Nucleic Acid Yield in Metastatic Castration-Resistant Prostate Cancer Biopsy Specimens. SHILAP Revista de lepidopterología. 3(1). 14–22. 7 indexed citations

Joseph, Jason, Amy E. Glasgow, Rachel E. Carlson, et al.. (2019). Screening Postoperative Hemoglobin after Robot-Assisted Radical Prostatectomy—Frequently Used, but Is It Necessary?. Urology Practice. 7(6). 554–558. 1 indexed citations

Colicchia, Michele, Alessandro Morlacco, Laureano J. Rangel, et al.. (2018). Role of Metabolic Syndrome on Perioperative and Oncological Outcomes at Radical Prostatectomy in a Low-risk Prostate Cancer Cohort Potentially Eligible for Active Surveillance. European Urology Focus. 5(3). 425–432. 11 indexed citations

Giridhar, Karthik V., Cristobal T. Sanhueza, David W. Hillman, et al.. (2018). Serum chromogranin-A-based prognosis in metastatic castration-resistant prostate cancer. Prostate Cancer and Prostatic Diseases. 21(3). 431–437. 19 indexed citations

Kohli, Manish, Jian Li, Meijun Du, et al.. (2018). Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patients. Prostate Cancer and Prostatic Diseases. 21(3). 411–418. 33 indexed citations

Giridhar, Karthik V., Cristobal T. Sanhueza, David W. Hillman, et al.. (2018). Prognostic value of chromogranin-a (CGA) compared to circulating tumor cells (CTCs) in metastatic castration resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 36(6_suppl). 249–249.

Morlacco, Alessandro, et al.. (2018). Impact of metabolic syndrome on oncologic outcomes at radical prostatectomy. Urologic Oncology Seminars and Original Investigations. 36(12). 528.e1–528.e6. 13 indexed citations

10.

Bhindi, Bimal, Rachel E. Carlson, Ross Mason, et al.. (2017). Long-term Follow-up of a Matched Cohort Study Evaluating the Role of Adjuvant Radiotherapy for Organ-confined Prostate Cancer With a Positive Surgical Margin. Urology. 109. 145–152. 5 indexed citations

11.

Hart, Steven N., Marissa S. Ellingson, Peter T. Vedell, et al.. (2016). Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancer. BMJ Open. 6(4). e010332–e010332. 28 indexed citations

12.

Morlacco, Alessandro, Vidit Sharma, Boyd R. Viers, et al.. (2016). The Incremental Role of Magnetic Resonance Imaging for Prostate Cancer Staging before Radical Prostatectomy. European Urology. 71(5). 701–704. 93 indexed citations

13.

Hearn, Jason W.D., Chad A. Reichard, C.A. Reddy, et al.. (2016). HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort study. The Lancet Oncology. 17(10). 1435–1444. 103 indexed citations

14.

Gershman, Boris, Sarah P. Psutka, Francis J. McGovern, et al.. (2015). Patient-reported Functional Outcomes Following Open, Laparoscopic, and Robotic Assisted Radical Prostatectomy Performed by High-volume Surgeons at High-volume Hospitals. European Urology Focus. 2(2). 172–179. 17 indexed citations

15.

Moschini, Marco, Alberto Briganti, Christopher R. Murphy, et al.. (2015). Outcomes for Patients with Clinical Lymphadenopathy Treated with Radical Prostatectomy. European Urology. 69(2). 193–196. 22 indexed citations

16.

Moreira, Daniel M., Boris Gershman, Stephen A. Boorjian, et al.. (2015). MP56-14 PREDICTORS AND ONCOLOGIC OUTCOMES OF PT0 PROSTATE CANCER IN RADICAL PROSTATECTOMY SPECIMENS. The Journal of Urology. 193(4S).

17.

Jatoi, Aminah, Carmen Radecki Breitkopf, Nathan R. Foster, et al.. (2014). A Mixed-Methods Feasibility Trial of Protein Kinase C Iota Inhibition with Auranofin in Asymptomatic Ovarian Cancer Patients. Oncology. 88(4). 208–213. 28 indexed citations

18.

Kaushik, Dharam, R. Jeffrey Karnes, Manuel S. Eisenberg, et al.. (2013). Effect of metformin on prostate cancer outcomes after radical prostatectomy. Urologic Oncology Seminars and Original Investigations. 32(1). 43.e1–43.e7. 47 indexed citations

19.

Thiel, David D., Eric J. Bergstralh, Rachel E. Carlson, et al.. (2013). Obese men have more advanced and more aggressive prostate cancer at time of surgery than non-obese men after adjusting for screening PSA level and age: results from two independent nested case–control studies. Prostate Cancer and Prostatic Diseases. 16(4). 352–356. 28 indexed citations

20.

Carlson, Rachel E., et al.. (1991). Breaking the INCEST CYCLE: The Group as a Surrogate Family. Journal of Psychosocial Nursing and Mental Health Services. 29(4). 28–32. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact